Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Montali

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Atherosclerosis|September 7, 2015
Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approachIlenia Minicocci, Cristina Prisco, Anna Montali, et al.
Atherosclerosis|September 14, 2010
Genetic variants in adipose triglyceride lipase influence lipid levels in familial combined hyperlipidemiaLuisa Nanni, Fabiana Quagliarini, Francesca Megiorni, et al.
The Journal of Pediatrics|February 6, 2017
Analysis of Children and Adolescents with Familial HypercholesterolemiaIlenia Minicocci, Simone Pozzessere, Cristina Prisco, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 18, 2019
Spectrum of Mutations and Long-Term Clinical Outcomes in Genetic Chylomicronemia SyndromesLaura D'Erasmo, Alessia Di Costanzo, Francesca Cassandra, et al.
Metabolism: Clinical and Experimental|October 9, 2002
Common variants in the lipoprotein lipase gene, but not those in the insulin receptor substrate-1, the beta3-adrenergic receptor, and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial combined hyperlipidemiaFilomena Campagna, Anna Montali, Marco Giorgio Baroni, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 25, 2020
Evolving trend in the management of heterozygous familial hypercholesterolemia in Italy: A retrospective, single center, observational studyLaura D'Erasmo, Daniela Commodari, Alessia Di Costanzo, et al.
Cardiology|March 20, 2010
Functional rs20417 SNP (-765G>C) of cyclooxygenase-2 gene does not predict the risk of recurrence of ischemic events in coronary patients: results of a 7-year prospective studyAnna Montali, Francesco Barillà, Gaetano Tanzilli, et al.
Haematologica|January 29, 2003
Interleukin-1 gene cluster polymorphisms and risk of coronary artery diseaseBranislav Vohnout, Augusto Di Castelnuovo, Roberto Trotta, et al.
Biochemical and Biophysical Research Communications|December 4, 2018
A novel splicing mutation in the ABCA1 gene, causing Tangier disease and familial HDL deficiency in a large familyMarianna Maranghi, Gessica Truglio, Antonio Gallo, et al.
Atherosclerosis|January 2, 2007
Detection of familial hypercholesterolemia in a cohort of children with hypercholesterolemia: results of a family and DNA-based screeningFilomena Campagna, Francesco Martino, Maura Bifolco, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Atherosclerosis|September 7, 2015
Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approachIlenia Minicocci, Cristina Prisco, Anna Montali, et al.
Atherosclerosis|September 14, 2010
Genetic variants in adipose triglyceride lipase influence lipid levels in familial combined hyperlipidemiaLuisa Nanni, Fabiana Quagliarini, Francesca Megiorni, et al.
The Journal of Pediatrics|February 6, 2017
Analysis of Children and Adolescents with Familial HypercholesterolemiaIlenia Minicocci, Simone Pozzessere, Cristina Prisco, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 18, 2019
Spectrum of Mutations and Long-Term Clinical Outcomes in Genetic Chylomicronemia SyndromesLaura D'Erasmo, Alessia Di Costanzo, Francesca Cassandra, et al.
Metabolism: Clinical and Experimental|October 9, 2002
Common variants in the lipoprotein lipase gene, but not those in the insulin receptor substrate-1, the beta3-adrenergic receptor, and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial combined hyperlipidemiaFilomena Campagna, Anna Montali, Marco Giorgio Baroni, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 25, 2020
Evolving trend in the management of heterozygous familial hypercholesterolemia in Italy: A retrospective, single center, observational studyLaura D'Erasmo, Daniela Commodari, Alessia Di Costanzo, et al.
Cardiology|March 20, 2010
Functional rs20417 SNP (-765G>C) of cyclooxygenase-2 gene does not predict the risk of recurrence of ischemic events in coronary patients: results of a 7-year prospective studyAnna Montali, Francesco Barillà, Gaetano Tanzilli, et al.
Haematologica|January 29, 2003
Interleukin-1 gene cluster polymorphisms and risk of coronary artery diseaseBranislav Vohnout, Augusto Di Castelnuovo, Roberto Trotta, et al.
Biochemical and Biophysical Research Communications|December 4, 2018
A novel splicing mutation in the ABCA1 gene, causing Tangier disease and familial HDL deficiency in a large familyMarianna Maranghi, Gessica Truglio, Antonio Gallo, et al.
Atherosclerosis|January 2, 2007
Detection of familial hypercholesterolemia in a cohort of children with hypercholesterolemia: results of a family and DNA-based screeningFilomena Campagna, Francesco Martino, Maura Bifolco, et al.
Pageof 5